Dan Hartman is a Director, Integrated Development; Interim Director, Malaria. Global Health at Bill & Melinda Gates Foundation. He possess expertise in clinical development, clinical trials, pharmacology, drug development, pharmaceutical industry and 32 more skills. Colleagues describe him as "Dan and I were colleagues in the Pfizer Cardiovascular Therapeutic Area from 2001-3. I was in R&D in the UK in Early Development (phase 1/2a), while Dan was in Ann Arbor in Clinical Research & Full Development (phase 2b/3). Dan was (and is) an outstanding clinical strategist, able to see the full picture required for a development plan that takes a compound from First-in-Man studies through Regulatory Submission and then into post-approval research. Dan can easily recognize the key issues or roadblocks and develop a strategy that addresses such issues cleanly and completely. Dan is also an experienced and talented operational drug developer, able to put together all the pieces required for an IND, a clinical protocol, a clinical study report, or the Clinical Section of an NDA. He and I worked together as colleagues on several projects while at Pfizer and I would recommend him without hesitation as a colleague or consultant in the CV / Metabolism area."